相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis
Kiyoshi Misawa et al.
MOLECULAR CARCINOGENESIS (2017)
Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets
Cameron Lindsay et al.
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)
Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis
Kiyoshi Misawa et al.
ONCOTARGET (2017)
Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer
Kiyoshi Misawa et al.
CLINICAL & EXPERIMENTAL METASTASIS (2016)
Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
Elena Ceccacci et al.
BRITISH JOURNAL OF CANCER (2016)
Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer
Kiyoshi Misawa et al.
ONCOTARGET (2016)
Emerging drugs for head and neck cancer
Yihui Wen et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
MethHC: a database of DNA methylation and gene expression in human cancer
Wei-Yun Huang et al.
NUCLEIC ACIDS RESEARCH (2015)
Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma
Kiyoshi Misawa et al.
PLOS ONE (2015)
Tumor Suppressor Activity and Inactivation of Galanin Receptor Type 2 by Aberrant Promoter Methylation in Head and Neck Cancer
Yuki Misawa et al.
CANCER (2014)
Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells
Takayuki Uehara et al.
CANCER SCIENCE (2014)
Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma
Pauline M. W. van Kempen et al.
EPIGENETICS (2014)
Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients
Stefano Pierini et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients
Rolf Warta et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The G Protein-Coupled Receptor GALR2 Promotes Angiogenesis in Head and Neck Cancer
Rajat Banerjee et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC
Takeharu Kanazawa et al.
MOLECULAR MEDICINE REPORTS (2014)
Biomarkers in Advanced Larynx Cancer
Carol R. Bradford et al.
LARYNGOSCOPE (2014)
Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
Chi T. Viet et al.
PLOS ONE (2014)
Characterization of HPV and host genome interactions in primary head and neck cancers
Michael a Parfenov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Epigenetics in radiotherapy: Where are we heading?
Kim M. Smits et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Predictive value of epigenetic alterations in head and neck squamous cell carcinoma
Jennifer Koffler et al.
MOLECULAR & CELLULAR ONCOLOGY (2014)
Clinical Correlates of Promoter Hypermethylation of Four Target Genes in Head and Neck Cancer: A Cooperative Group Correlative Study
Jong-Lyel Roh et al.
CLINICAL CANCER RESEARCH (2013)
Unique DNA Methylation Loci Distinguish Anatomic Site and HPV Status in Head and Neck Squamous Cell Carcinoma
Roberto A. Lleras et al.
CLINICAL CANCER RESEARCH (2013)
GALR1 Methylation in Vaginal Swabs Is Highly Accurate in Identifying Women With Endometrial Cancer
Konstantinos Doufekas et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Frequent promoter hypermethylation of tachykinin-1 and tachykinin receptor type 1 is a potential biomarker for head and neck cancer
Kiyoshi Misawa et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas
Efterpi Kostareli et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Galanin stimulates neurite outgrowth from sensory neurons by inhibition of Cdc42 and Rho GTPases and activation of cofilin
Sally-Ann Hobson et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma
Kowan Ja Jee et al.
MODERN PATHOLOGY (2013)
Epigenetic Modulation of Signal Transduction Pathways in HPV-Associated HNSCC
Maria J. Worsham et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2013)
Comprehensive Analysis of DNA Methylation in Head and Neck Squamous Cell Carcinoma Indicates Differences by Survival and Clinicopathologic Characteristics
Justin A. Colacino et al.
PLOS ONE (2013)
Preferential Activation of the Hedgehog Pathway by Epigenetic Modulations in HPV Negative HNSCC Identified with Meta-Pathway Analysis
Elana J. Fertig et al.
PLOS ONE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Galanin Has Tumor Suppressor Activity and Is Frequently Inactivated by Aberrant Promoter Methylation in Head and Neck Cancer
Kiyoshi Misawa et al.
TRANSLATIONAL ONCOLOGY (2013)
Identification and functional validation of HPV-mediated hypermethylation in head and neck squamous cell carcinoma
Matthias Lechner et al.
GENOME MEDICINE (2013)
Prognostic value of human papillomavirus and squamous cell carcinoma antigen in head and neck squamous cell carcinoma
Zeyi Deng et al.
CANCER SCIENCE (2012)
Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance
Takenori Ogawa et al.
CELL CYCLE (2012)
Downregulation of SMG-1 in HPV-Positive Head and Neck Squamous Cell Carcinoma Due to Promoter Hypermethylation Correlates with Improved Survival
Evgenia Gubanova et al.
CLINICAL CANCER RESEARCH (2012)
Novel targeted therapies in head and neck cancer
Mariana B. A. Ferreira et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Epigenetic mechanisms in oral carcinogenesis
Jacqueline A. Gasche et al.
FUTURE ONCOLOGY (2012)
Role of Neurofilament Light Polypeptide in Head and Neck Cancer Chemoresistance
Baishen Chen et al.
MOLECULAR CANCER RESEARCH (2012)
Antitumor Mechanisms of Targeting the PDK1 Pathway in Head and Neck Cancer
Neil E. Bhola et al.
MOLECULAR CANCER THERAPEUTICS (2012)
New concepts for translational head and neck oncology: lessons from HPV-related oropharyngeal squamous cell carcinomas
Efterpi Kostareli et al.
FRONTIERS IN ONCOLOGY (2012)
Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma
Rajat Banerjee et al.
CELLULAR SIGNALLING (2011)
Targeting GPCR-Mediated p70S6K Activity May Improve Head and Neck Cancer Response to Cetuximab
Neil E. Bhola et al.
CLINICAL CANCER RESEARCH (2011)
Genome-wide identification of possible methylation markers chemosensitive to targeted regimens in colorectal cancers
Jin C. Kim et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
G protein-coupled receptors: novel targets for drug discovery in cancer
Rosamaria Lappano et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa
Jaroslaw Paluszczak et al.
ORAL ONCOLOGY (2011)
Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas
Gordana Supic et al.
ORAL ONCOLOGY (2011)
Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma
Takeharu Kanazawa et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
A DNA Methyltransferase Inhibitor and All-trans Retinoic Acid Reduce Oral Cavity Carcinogenesis Induced by the Carcinogen 4-Nitroquinoline 1-Oxide
Xiao-Han Tang et al.
CANCER PREVENTION RESEARCH (2009)
Galanin Receptor Subtype 2 Suppresses Cell Proliferation and Induces Apoptosis in p53 Mutant Head and Neck Cancer Cells
Takeharu Kanazawa et al.
CLINICAL CANCER RESEARCH (2009)
The Galanin Signaling Cascade is a Candidate Pathway Regulating Oncogenesis in Human Squamous Cell Carcinoma
Takashi Sugimoto et al.
GENES CHROMOSOMES & CANCER (2009)
Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma
Ajay Matta et al.
HEAD & NECK ONCOLOGY (2009)
Expression of p53 and Bcl-xL as predictive markers for larynx preservation in advanced laryngeal cancer
Bhavna Kumar et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2008)
Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomas
H. K. Tan et al.
BRITISH JOURNAL OF CANCER (2008)
Expanding role of the medical oncologist in the management of head and neck cancer
Nicholas Choong et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma
Carmen J. Marsit et al.
CANCER (2008)
Cancer Prevention: Epigenetics Steps Up to the Plate
Jean-Pierre Issa
CANCER PREVENTION RESEARCH (2008)
Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer
Kiyoshi Misawa et al.
CLINICAL CANCER RESEARCH (2008)
Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy
Bret B. Friday et al.
CLINICAL CANCER RESEARCH (2008)
Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling
Woonbok Chung et al.
PLOS ONE (2008)
Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GaIR2)
R. Tofighi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The galanin peptide family: Receptor phan-nacology, pleiotropic biological actions, and implications in health and disease
Roland Lang et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors
T. Kanazawa et al.
ONCOGENE (2007)
DNA methylation as a therapeutic target in cancer
Jean-Pierre J. Issa
CLINICAL CANCER RESEARCH (2007)
Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma
BS Henson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Multiple mechanisms downregulate CDKN1C in human bladder cancer
MJ Hoffmann et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Loss of E-cadherin and p27 expression is associated with head and neck squarnous tumorigenesis
E Massarelli et al.
CANCER (2005)
Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells
A Berger et al.
ENDOCRINOLOGY (2004)
sst2 somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation
H Lahlou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Methylation profiling of twenty four genes and the concordant methylation behaviours of nineteen genes that may contribute to hepatocellular carcinogenesis
J Yu et al.
CELL RESEARCH (2003)
Cyclic AMP-independent involvement of Rap1/B-Raf in the angiotensin II AT2 receptor signaling pathway in NG108-15 cells
L Gendron et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Epigenetics in cancer: implications for early detection and prevention
M Verma et al.
LANCET ONCOLOGY (2002)
Bradykinin B1 receptor blocks PDGF-induced mitogenesis by prolonging ERK activation and increasing p27Kip1
BS Dixon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
Patterns of gene promoter methylation in squamous cell cancer of the head and neck
M Hasegawa et al.
ONCOGENE (2002)
Res-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists
O Kranenburg et al.
ONCOGENE (2001)
The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to Gq, Gi and G12 proteins
N Wittau et al.
ONCOGENE (2000)
分享论文
